RC Ash

3.6k total citations · 1 hit paper
32 papers, 2.4k citations indexed

About

RC Ash is a scholar working on Hematology, Immunology and Molecular Biology. According to data from OpenAlex, RC Ash has authored 32 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Hematology, 10 papers in Immunology and 6 papers in Molecular Biology. Recurrent topics in RC Ash's work include Hematopoietic Stem Cell Transplantation (22 papers), Chronic Myeloid Leukemia Treatments (7 papers) and T-cell and B-cell Immunology (6 papers). RC Ash is often cited by papers focused on Hematopoietic Stem Cell Transplantation (22 papers), Chronic Myeloid Leukemia Treatments (7 papers) and T-cell and B-cell Immunology (6 papers). RC Ash collaborates with scholars based in United States. RC Ash's co-authors include MM Horowitz, Gale Rp, JM Goldman, Dicke Ka, RE Champlin, William R. Drobyski, Good Ra, DW van Bekkum, K A Sobocinski and A Marmont and has published in prestigious journals such as Journal of Clinical Oncology, Blood and American Journal of Roentgenology.

In The Last Decade

RC Ash

32 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

T-cell depletion of HLA-identical transplants in leukemia

1991 581 citations A Marmont, MM Horowitz et al. Blood profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
RC Ash United States	21	1.9k	723	539	486	434	32	2.4k
AA Fauser Germany	22	1.6k 0.8×	490 0.7×	399 0.7×	370 0.8×	469 1.1×	63	2.1k
Dicke Ka United States	26	1.9k 1.0×	982 1.4×	338 0.6×	684 1.4×	523 1.2×	89	2.8k
Franco Locatelli Italy	22	1.9k 1.0×	704 1.0×	365 0.7×	438 0.9×	826 1.9×	46	2.5k
FR Appelbaum United States	17	1.9k 1.0×	384 0.5×	338 0.6×	647 1.3×	571 1.3×	19	2.4k
RE Champlin United States	28	2.7k 1.4×	912 1.3×	531 1.0×	1.0k 2.1×	869 2.0×	50	3.4k
HJ Kolb Germany	22	2.9k 1.5×	1.5k 2.1×	653 1.2×	810 1.7×	620 1.4×	50	3.7k
P. B. Mcglave United States	19	1.3k 0.7×	472 0.7×	329 0.6×	394 0.8×	357 0.8×	24	1.7k
Paolo Di Bartolomeo Italy	21	2.0k 1.0×	778 1.1×	662 1.2×	678 1.4×	437 1.0×	87	2.5k
S. D. Lawler United Kingdom	20	1.5k 0.8×	344 0.5×	673 1.2×	290 0.6×	469 1.1×	38	2.1k
Aruna Raghavachar Germany	22	1.5k 0.8×	516 0.7×	164 0.3×	497 1.0×	495 1.1×	55	2.1k

Countries citing papers authored by RC Ash

Since Specialization

Citations

This map shows the geographic impact of RC Ash's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by RC Ash with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites RC Ash more than expected).

Fields of papers citing papers by RC Ash

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by RC Ash. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by RC Ash. The network helps show where RC Ash may publish in the future.

Co-authorship network of co-authors of RC Ash

This figure shows the co-authorship network connecting the top 25 collaborators of RC Ash. A scholar is included among the top collaborators of RC Ash based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with RC Ash. RC Ash is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Gluckman, Éliane, AD Auerbach, MM Horowitz, et al.. (1995). Bone marrow transplantation for Fanconi anemia. Blood. 86(7). 2856–2862. 163 indexed citations

2.

Sarode, Ravi, JG McFarland, Neal Flomenberg, et al.. (1995). Therapeutic plasma exchange does not appear to be effective in the management of thrombotic thrombocytopenic purpura/hemolytic uremic syndrome following bone marrow transplantation.. PubMed. 16(2). 271–5. 73 indexed citations

3.

Gluckman, Éliane, AD Auerbach, MM Horowitz, et al.. (1995). Bone marrow transplantation for Fanconi anemia. Blood. 86(7). 2856–2862. 32 indexed citations

4.

Drobyski, William R., RC Ash, JT Casper, et al.. (1994). Effect of T-cell depletion as graft-versus-host disease prophylaxis on engraftment, relapse, and disease-free survival in unrelated marrow transplantation for chronic myelogenous leukemia. Blood. 83(7). 1980–1987. 11 indexed citations

5.

Drobyski, William R., RC Ash, JT Casper, et al.. (1994). Effect of T-cell depletion as graft-versus-host disease prophylaxis on engraftment, relapse, and disease-free survival in unrelated marrow transplantation for chronic myelogenous leukemia. Blood. 83(7). 1980–1987. 104 indexed citations

6.

Cohen, Eric P., C.A. Lawton, J. E. Moulder, C G Becker, & RC Ash. (1993). Clinical Course of Late-Onset Bone Marrow Transplant Nephropathy. The Nephron journals/Nephron journals. 64(4). 626–635. 66 indexed citations

7.

Drobyski, William R., CA Keever, MS Roth, et al.. (1993). Salvage immunotherapy using donor leukocyte infusions as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation: efficacy and toxicity of a defined T-cell dose. Blood. 82(8). 2310–2318. 277 indexed citations

8.

Stroncek, DF, R. L. Simmons, JH Antin, et al.. (1993). Experiences of the first 493 unrelated marrow donors in the National Marrow Donor Program. Blood. 81(7). 1940–1946. 77 indexed citations

9.

Stroncek, DF, R. L. Simmons, JH Antin, et al.. (1993). Experiences of the first 493 unrelated marrow donors in the National Marrow Donor Program. Blood. 81(7). 1940–1946. 4 indexed citations

10.

Barrett, AJ, MM Horowitz, RC Ash, et al.. (1992). Bone marrow transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia. Blood. 79(11). 3067–3070. 6 indexed citations

11.

Barrett, AJ, RC Ash, K Atkinson, et al.. (1992). Bone marrow transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia. Blood. 79(11). 3067–3070. 179 indexed citations

12.

Casper, J., Gerald Sedmak, Richard E. Harris, et al.. (1992). Intravenous immunoglobulin: use in pediatric bone marrow transplantation.. PubMed. 29(3 Suppl 2). 100–5. 5 indexed citations

13.

Marmont, A, MM Horowitz, Gale Rp, et al.. (1991). T-cell depletion of HLA-identical transplants in leukemia. Blood. 78(8). 2120–2130. 40 indexed citations

14.

Drobyski, William R., Stephen N. Thibodeau, R L Truitt, et al.. (1989). Third-party-mediated graft rejection and graft-versus-host disease after T-cell-depleted bone marrow transplantation, as demonstrated by hypervariable DNA probes and HLA-DR polymorphism. Blood. 74(6). 2285–2294. 2 indexed citations

15.

Goodman, Linnea R., et al.. (1989). Pneumatosis intestinalis in bone-marrow transplantation patients: diagnosis on routine chest radiographs. American Journal of Roentgenology. 152(5). 991–994. 21 indexed citations

16.

Bunin, Nancy, J. Casper, Christopher R. Chitambar, et al.. (1988). Partially matched bone marrow transplantation in patients with myelodysplastic syndromes.. Journal of Clinical Oncology. 6(12). 1851–1855. 35 indexed citations

17.

Ash, RC, et al.. (1982). Normal human pluripotential and committed hematopoietic progenitors do not express the p24 antigen detected by monoclonal antibody BA-2: implications for immunotherapy of lymphocytic leukemia. Blood. 60(6). 1310–1316. 10 indexed citations

18.

Lasky, LC, et al.. (1982). Collection of pluripotential hematopoietic stem cells by cytapheresis. Blood. 59(4). 822–827. 1 indexed citations

19.

Lasky, LC, et al.. (1982). Collection of pluripotential hematopoietic stem cells by cytapheresis. Blood. 59(4). 822–827. 51 indexed citations

20.

Ash, RC, et al.. (1981). Studies of human pluripotential hemopoietic stem cells (CFU-GEMM) in vitro. Blood. 58(2). 309–316. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact